Customize
Quick Links
Specialties

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie and Bayer HealthCare Pharmaceuticals.

Community Practice Connections™: 3rd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies

Release Date: November 28, 2018
Expiration Date: November 28, 2019
Media: Internet - based

Activity Overview

Community Practice Connections™: 3rd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies consists of a series of interactive clinical vignettes, short video interviews with leading experts in lymphoid malignancies, and brief summaries of clinical data related to these issues. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie and Bayer HealthCare Pharmaceuticals.

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, and physician assistants) involved in the treatment and management of patients with hematologic malignancies.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  1. Appraise testing strategies that may inform clinical decision-making in the management of hematologic malignancies
  2. Apply clinical trial results to multiple lines of care in the management of hematologic malignancies
  3. Outline strategies to monitor and proactively manage treatment-related toxicities in patients with leukemia, lymphoma, and multiple myeloma
  4. Identify key emerging data pertaining to the diagnosis and management of patients with hematologic malignancies

Faculty, Staff, and Planners' Disclosures

Faculty

Renier J. Brentjens, MD, PhD
Director, Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, NY
 
 

Disclosures: Grant/Research Support: Juno Therapeutics; Consultant: Juno Therapeutics

Peter Hillmen, MB ChB, PhD
Professor of Experimental Hematology
University of Leeds
Leeds, United Kingdom
 
 

Disclosures: Grant/Research Support: AbbVie, Janssen, Pharmacyclics, Gilead, Roche, GlaxoSmithKline; Speakers Bureau: AbbVie, Janssen, Gilead, GlaxoSmithKline

María-Victoria Mateos, MD, PhD
Associate Professor of Hematology
University Hospital of Salamanca
Salamanca, Spain
 
 

Disclosures: Grant/Research Support: Celgene; Consultant: Celgene, Janssen, Amgen, Takeda, AbbVie

Gilles A. Salles, MD, PhD
University Professor
Head of Hematology
Université Claude Bernard Lyon-1
Hospices Civils de Lyon
Lyon, France

Disclosures: Grant/Research Support: Roche; Consultant: Amgen, Bristol-Myers Squibb, Celgene, Gilead, Janssen, Kite Pharma, Merck, MorphoSys, Novartis, Roche, Servier

Anas Younes, MD
Professor and Chief, Lymphoma Service
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
 

Disclosures: Grant/Research Support: Novartis, Johnson & Johnson, Curis, Roche, Bristol-Myers Squibb; Consultant: Bayer, Bristol-Myers Squibb, Celgene, Incyte, Janssen, Sanofi, Seattle Genetics, Takeda, Millennium, Genentech, Merck

The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.







Become a Member

Forgot Password?
Filter By